Open AccessPractical considerations of nebulized corticosteroid in children with acute asthmatic exacerbation: A consensus
Author(s) -
C. Direkwattanachai,
Chalermthai Aksilp,
Pantipa Chatchatee,
Orathai Jirapongsananuruk,
Harutai Kamalaporn,
Wasu Kamchaisatian,
Sorasak Lochindarat,
Ligamtrakulpanit,
Orapan Poachanukoon,
Muthita Trakultivakorn,
Jamaree Teeratakulpisarn,
Kanokporn Udomittipong,
Mukda Vangveeravong,
Jitladda Deerojanawong
Publication year - 2021
Publication title -
asian pacific journal of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 33
ISSN - 0125-877X
DOI - 10.12932/ap-170918-0407
Subject(s) - medicine , exacerbation , corticosteroid , budesonide , asthma , randomized controlled trial , bronchodilator , placebo , fluticasone , clinical trial , intensive care medicine , anesthesia , alternative medicine , pathology
Acute asthmatic exacerbation in children causes economic burdens both directly and indirectly. The GINA guideline does mention the use of inhaled or oral corticosteroids in the treatment of asthmatic exacerbation, it provides little practical guidance on the use of nebulized corticosteroid.